Atomistry » Chlorine » PDB 4wk3-4ws1 » 4wk7
Atomistry »
  Chlorine »
    PDB 4wk3-4ws1 »
      4wk7 »

Chlorine in PDB 4wk7: Crystal Structure of Human Adamts-4 in Complex with Inhibitor (Compound 1, 2-(4-Chlorophenoxy)-N-{[(4R)-4-Methyl-2,5- Dioxoimidazolidin-4-Yl]Methyl} Acetamide)

Enzymatic activity of Crystal Structure of Human Adamts-4 in Complex with Inhibitor (Compound 1, 2-(4-Chlorophenoxy)-N-{[(4R)-4-Methyl-2,5- Dioxoimidazolidin-4-Yl]Methyl} Acetamide)

All present enzymatic activity of Crystal Structure of Human Adamts-4 in Complex with Inhibitor (Compound 1, 2-(4-Chlorophenoxy)-N-{[(4R)-4-Methyl-2,5- Dioxoimidazolidin-4-Yl]Methyl} Acetamide):
3.4.24.82;

Protein crystallography data

The structure of Crystal Structure of Human Adamts-4 in Complex with Inhibitor (Compound 1, 2-(4-Chlorophenoxy)-N-{[(4R)-4-Methyl-2,5- Dioxoimidazolidin-4-Yl]Methyl} Acetamide), PDB code: 4wk7 was solved by J.D.Durbin, S.L.Stout, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 13.72 / 1.24
Space group P 21 21 21
Cell size a, b, c (Å), α, β, γ (°) 40.506, 67.923, 74.581, 90.00, 90.00, 90.00
R / Rfree (%) 19.6 / 21.3

Other elements in 4wk7:

The structure of Crystal Structure of Human Adamts-4 in Complex with Inhibitor (Compound 1, 2-(4-Chlorophenoxy)-N-{[(4R)-4-Methyl-2,5- Dioxoimidazolidin-4-Yl]Methyl} Acetamide) also contains other interesting chemical elements:

Calcium (Ca) 3 atoms
Zinc (Zn) 1 atom

Chlorine Binding Sites:

The binding sites of Chlorine atom in the Crystal Structure of Human Adamts-4 in Complex with Inhibitor (Compound 1, 2-(4-Chlorophenoxy)-N-{[(4R)-4-Methyl-2,5- Dioxoimidazolidin-4-Yl]Methyl} Acetamide) (pdb code 4wk7). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Crystal Structure of Human Adamts-4 in Complex with Inhibitor (Compound 1, 2-(4-Chlorophenoxy)-N-{[(4R)-4-Methyl-2,5- Dioxoimidazolidin-4-Yl]Methyl} Acetamide), PDB code: 4wk7:

Chlorine binding site 1 out of 1 in 4wk7

Go back to Chlorine Binding Sites List in 4wk7
Chlorine binding site 1 out of 1 in the Crystal Structure of Human Adamts-4 in Complex with Inhibitor (Compound 1, 2-(4-Chlorophenoxy)-N-{[(4R)-4-Methyl-2,5- Dioxoimidazolidin-4-Yl]Methyl} Acetamide)


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Crystal Structure of Human Adamts-4 in Complex with Inhibitor (Compound 1, 2-(4-Chlorophenoxy)-N-{[(4R)-4-Methyl-2,5- Dioxoimidazolidin-4-Yl]Methyl} Acetamide) within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl505

b:17.4
occ:1.00
CL1 A:3PQ505 0.0 17.4 1.0
C18 A:3PQ505 1.7 16.4 1.0
C20 A:3PQ505 2.7 16.1 1.0
C17 A:3PQ505 2.7 16.3 1.0
CG2 A:VAL398 3.7 19.7 1.0
O A:VAL390 3.7 11.9 1.0
CB A:PHE357 3.8 12.5 1.0
CA A:VAL390 3.9 12.7 1.0
C21 A:3PQ505 4.0 16.0 1.0
C16 A:3PQ505 4.0 16.2 1.0
CG A:MET395 4.0 20.0 1.0
O A:HOH709 4.0 27.6 1.0
CD1 A:PHE357 4.2 14.5 1.0
C A:VAL390 4.3 12.2 1.0
O A:PHE357 4.3 10.9 1.0
CG A:PHE357 4.4 13.8 1.0
O A:HIS389 4.4 14.0 1.0
CA A:MET395 4.5 19.5 1.0
C15 A:3PQ505 4.5 16.1 1.0
C A:PHE357 4.5 10.9 1.0
O A:ALA396 4.6 21.0 1.0
CB A:MET395 4.6 19.7 1.0
CA A:PHE357 4.6 11.7 1.0
CG1 A:VAL390 4.7 12.6 1.0
CB A:VAL390 4.7 12.8 1.0
CG2 A:VAL390 4.8 13.0 1.0
N A:VAL390 4.8 13.4 1.0
N A:ALA396 4.9 20.6 1.0
C A:HIS389 4.9 14.8 1.0
CE A:MET395 4.9 19.8 1.0

Reference:

T.B.Durham, V.J.Klimkowski, C.J.Rito, J.Marimuthu, J.L.Toth, C.Liu, J.D.Durbin, S.L.Stout, L.Adams, C.Swearingen, C.Lin, M.G.Chambers, K.Thirunavukkarasu, M.R.Wiley. Identification of Potent and Selective Hydantoin Inhibitors of Aggrecanase-1 and Aggrecanase-2 That Are Efficacious in Both Chemical and Surgical Models of Osteoarthritis. J.Med.Chem. 2014.
ISSN: ISSN 0022-2623
PubMed: 25415648
DOI: 10.1021/JM501522N
Page generated: Sat Dec 12 11:18:12 2020

Last articles

Zn in 7VD8
Zn in 7V1R
Zn in 7V1Q
Zn in 7VPF
Zn in 7T85
Zn in 7T5F
Zn in 7NF9
Zn in 7M4M
Zn in 7M4O
Zn in 7M4N
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy